K.B. BEKTUR¹, M.E. ZHELEZOVA¹, L.I. MALTSEVA², R.I. SHARIPOVA¹

 ¹Kazan (Volga) Federal University, Kazan

²Kazan State Medical Academy — Branch Campus of the FSBEI FPE RMACPE MOH Russia, Kazan

Contact details:

Bektur K.B. — obstetrician-gynecologist of the Department of Gynecology

Address: 18 Kremlevskaya St., 420008 Kazan, Russian Federation, tel.: +(350)312-99-63, e-mail: bekturbegimai@gmail.com

 The purpose was to analyze the Russian and foreign scientific publications on the condition of newborns, children, teenagers and adults born with fetal growth restriction (FGR).

Material and methods. We analyzed scientific papers published and posted in Cochrane, Pubmed, Elsevier, and E-library databases.

Results. Numerous studies show that the impact of FGR extends not only to the early neonatal period, but also to the child’s further development and reduces the quality of life of the child and adult, affecting cognitive functions and causing neurological, metabolic, cardiovascular, respiratory, reproductive and visual impairments.

Conclusion. It is necessary to monitor not only newborns, but also children and adults born with FGR in order to minimize the risks of short-term and long-term outcomes.

Key words: neonatal outcomes of FGR, infant outcomes of FGR, adolescent outcomes of FGR, long-term outcomes of FGR, adult outcomes of FGR.

REFERENCES

1. Klinicheskie rekomendatsii “Nedostatochnyy rost ploda, trebuyushchiy predostavleniya meditsinskoy pomoshchi materi (zaderzhka rosta ploda)”, 2023 [Clinical guidelines «Insufficient fetal growth requiring medical care to the mother (fetal growth retardation)», 2023] (accessed on: 07.03.25)
2. Ananth C.V, Peltier M.R., Chavez M.R. et al. Recurrence of ischemic placental disease. Obstet. Gynecol, 2007, vol. 110 (1), p. 33.
3. Kramer M.S., Platt R., Yang H. et al. Are all growth-restricted newborns created equal(ly). Pediatrics, 1999, vol. 103 (3), pp. 599–602.
4. Zhelezova M.E., Mal’tseva L.I., Bektur k.B. et al. The Importance of Maternal Microbiome in the Development of Late Fetal Growth Restriction. Prakticheskaya meditsina, 2022, vol. 20, no. 5, pp. 34–39 (in Russ.).
5. Zhelezova M.E., Bektur B.K., Maltseva L.I. et al. Maternal gut microbiome and its impact on developing idiopathic late fetal growth retardation. Obstet. Gynecol. Reprod, 2024, vol. 18 (6), pp. 788–799 (in Russ).
6. Tu X., Duan C., Lin B. et al. Characteristics of the gut microbiota in pregnant women with fetal growth restriction. BMC Pregnancy Childbirth, 2022, vol. 22 (1), pp. 297.
7. Catherine Sch., Siri K, James A. et al. Cohort profile: The WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort (WHO-CMRS) to identify predictors of mortality through early childhood. MedRxiv, 2024.
8. Kuklina L.V., Kravchenko E.N., Krivchik G.V. The role of infectious factors in the formation of fetal growth retardation and gestation outcomes. Mat’ i ditya v Kuzbasse, 2020, no. 2, pp. 20–25 (in Russ.).
9. Li L., Zhang X., Shi Q. et al. Ultrasonographic findings and prenatal diagnosis of complete trisomy 17p syndrome: a case report and review of the literature. J. Clin. Lab. Anal, 2021, vol. 35, rr. 23582.
10. Peng Y., Pang J., Hu J. et al. Clinical and molecular characterization of 12 prenatal cases of Cri-Du-Chat syndrome. Mol. Genet. Genom. Med, 2020, no. 8, rr. 1312.
11. Yuan M., Deng L., Yang Y., Sun L. Intrauterine phenotype features of fetuses with Williams-Beuren syndrome and literature review. Ann. Hum. Genet, 2020, vol. 84, rr. 169–176.
12. Tzadikevitch Geffen K., Singer A., Maya I. et al. The yield of chromosomal microarray in pregnancies complicated with fetal growth restriction can be predicted according to clinical parameters. Fetal. Diagn. Ther, 2021, vol. 48, rr. 140–148.
13. Winsloe C., Elhindi J., Vieira M.C. et al. Perinatal outcomes after selective third-trimester ultrasound screening for small-for-gestational age: prospective cohort study nested within DESiGN randomized controlled trial. Ultrasound Obstet. Gynecol, 2025, vol. 65 (1), pp. 30–38.
14. Sharma D., Shastri S., Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin. Med. Insights Pediatr, 2016, vol. 10, pp. 67–83. DOI: 10.4137/CMPed.S40070
15. Giussani D.A. The fetal brain sparing response to hypoxia: physiological mechanisms. J. Physiol, 2016, vol. 594 (5), pp. 1215–1230.
16. Murray E., Fernandes M., Fazel M. et al. Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review. BJOG, 2015, vol. 122 (8), pp. 1062–1072.
17. Yawno T., Sutherland A.E., Pham Y. et al. Fetal Growth Restriction Alters Cerebellar Development in Fetal and Neonatal Sheep. Front. Physiol, 2019, vol. 10, pp. 560.
18. Misan N., Michalak S., Kapska K. et al. Blood-Brain barrier disintegration in growth-restricted fetuses with brain sparing effect. Int. J. Mol. Sci, 2022, vol. 23, pp. 12349.
19. Ancel P.Y., Goffinet F. EPIPAGE 2: a preterm birth cohort in France in 2011. BMC Pediatr, 2014, pp. 14–97.
20. Gephart S.M., Wetzel C., Krisman B. Prevention and early recognition of necrotizing enterocolitis: a tale of 2 tools-eNEC and GutCheckNEC. Adv. Neonatal. Care, 2014, vol. 14 (3), pp. 201–210.
21. Panakhova N.F. The role of mucosal defense in intestinal injury of infants with fetal growth retardation. Iran J. Pediatr, 2016, vol. 26 (1), pp. 460.
22. Lee J.W., VanderVeen D., Allred E.N., Leviton A. et al. Prethreshold retinopathy in premature infants with intrauterine growth restriction. Acta Paediatr, 2015, vol. 104 (1), pp. 27–31.
23. Gordon S.M., O’Connell A.E. Inborn errors of immunity in the premature infant: challenges in recognition and diagnosis. Front. Immunol, 2021, vol. 24 (12), 758373.
24. Tröger B., Müller T., Faust K. et al. Intrauterine growth restriction and the innate immune system in preterm infants of ≤32 weeks gestation. Neonatology, 2013, vol. 103 (3), pp. 199–204.
25. Soudée S., Vuillemin L., Alberti C. et al. Fetal growth restriction is worse than extreme prematurity for the developing lung. Neonatology, 2014, vol. 106 (4), pp. 304–310.
26. Sasi A., Abraham V., Davies-Tuck M. et al. Impact of intrauterine growth restriction on preterm lung disease. Acta Paediatr, 2015, vol. 104 (12), pp. 552–556.
27. Min Mu, Song Ye, Ming-Jie Bai et al. Birth weight and subsequent risk of asthma: a systematic review and meta-analysis. Heart Lung Circ, 2014, vol. 23 (6), pp. 511–519.
28. Laccourreye O., Maisonneuve H. French scientific medical journals confronted by developments in medical writing and the transformation of the medical press. Eur. Ann. Otorhinolaryngol. Head Neck Dis, 2019, vol. 136 (6), pp. 475–480.
29. Ovsyannikov D.Yu., Krsheminskaya I.V. Immunoprophylaxis of respiratory syncytial virus infection: why is it important from an epidemiological and clinical point of view. Neonatologiya: novosti, mneniya, obuchenie, 2017, no. 2, pp. 34–49 (in Russ.).
30. Patel D., Chawla J., Blavo C. Use of the Abrysvo vaccine in pregnancy to prevent respiratory syncytial virus in infants: a review. Cureus, 2024, vol. 16 (8), pp. 68349.
31. Zanardo V., Visentin S., Trevisanuto D. et al. Fetal aortic wall thickness: a marker of hypertension in IUGR children? Hypertens Res, 2013, vol. 36 (5), pp. 440–443.
32. Patey O., Carvalho J.S., Thilaganathan B. Perinatal changes in cardiac geometry and function in growth-restricted fetuses at term. Ultrasound Obstet. Gynecol, 2019, vol. 53, pp. 655–662.
33. Ho S.Y., Yuliana M.E., Chou H.C. et al. Intrauterine growth restriction alters kidney metabolism at the end of nephrogenesis. Nutr. Metab. (Lond), 2023, vol. 20, pp. 50.
34. Sacchi C., Marino C., Nosarti C. et al. Association of intrauterine growth restriction and small for gestational age status with childhood cognitive outcomes: a systematic review and meta-analysis. JAMA Pediatr, 2020, vol. 174 (8), pp. 772–781.
35. Costantine M.M., Tita A.T.N., Mele L. et al. The association between infant birth weight, head circumference, and neurodevelopmental outcomes. Am. J. Perinatol, 2024, vol. 41 (S 01), pp. 1313–1323.
36. Rios N.V., Fernandes L., Andrade C.L. et al. Evidence of changes in the oral language in children born full-term and small for gestational age: a systematic review. Revista Paulista De Pediatria, 2022, vol. 40. e2021049.
37. Taiar H., Benum S.D., Aakvik K.A.D. et al. Motor outcomes in individuals born small for gestational age at term: a systematic review. BMC Pediatr, 2024, vol. 24, pp. 718.
38. Ross M.G., Beall M.H. Adult sequelae of intrauterine growth restriction. Semin. Perinatol, 2008, vol. 32 (3), pp. 213–218.
39. Børte S., Winsvold B.S., Stensland S.Ø. et al. The effect of fetal growth restriction on the development of migraine and tension-type headache in adulthood. The HUNT Study. PLoS One, 2017, vol. 12 (4). e0175908.
40. Meng F., Yao M., Li S. et al. The impact of impaired intrauterine growth on male fertility: A systematic review and meta-analysis. Andrology, 2024, vol. 12, pp. 1651–1660.
41. Dupont C., Cordier A.G., Junien C. et al. Maternal environment and the reproductive function of the offspring. Theriogenology, 2012, vol. 78 (7), pp. 1405–1414.
42. Harvey M.E., David A.L., Dyer J. et al. Pregnant women’s experiences and perceptions of participating in the EVERREST prospective study; a qualitative study. BMC Pregnancy. Childbirth, 2019, vol. 19 (1), p. 144.
43. Lefkou E., Varoudi K., Pombo J. et al. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism. Biochem. Pharmacol, 2020, vol. 182, pp. 114217.
44. Jurisic Z., Jurisic E., Lefkou, G. et al. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction. Vascul. Pharmacol, 2021, vol. 137, rr. 106824.
45. Kupferminc M.J., Kliger C., Rimon E. et al. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications — a pilot study. J. Matern. Fetal. Neonatal. Med, 2022, vol. 35 (25), rr. 8055–8061.
46. Halkjær S.I., Knegt V.E., Sheng Lo B.Z et al. Multistrain probiotic increases the gut microbiota diversity in obese pregnant women: results from a randomized, double-blind placebo-controlled study. Curr. Develop. Nutr, 2020, vol. 4 (7).
47. Sharp A., Cornforth C., Jackson R. et al. The efficacy of sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction: the STRIDER RCT. Southampton (UK): national institute for health and care research. Effic. Mech. Evaluation, 2024, no. 11, pp. 18.